Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
DRKS00013730Phase 2Recruiting
- Sponsor
- University of Zurich
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in retinopathy of prematurity (ROP) comparing Oral propranolol with Placebo (2 arms). Started Jan 2018; status: recruiting.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on DRKS00013730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00013730.